EP2847340A2 - Mehrstufiges fermentationsverfahren ausgehend von synthesegas - Google Patents
Mehrstufiges fermentationsverfahren ausgehend von synthesegasInfo
- Publication number
- EP2847340A2 EP2847340A2 EP13728123.4A EP13728123A EP2847340A2 EP 2847340 A2 EP2847340 A2 EP 2847340A2 EP 13728123 A EP13728123 A EP 13728123A EP 2847340 A2 EP2847340 A2 EP 2847340A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- acetate
- microorganism
- clostridium
- ethanol
- process step
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000015572 biosynthetic process Effects 0.000 title claims description 25
- 238000003786 synthesis reaction Methods 0.000 title claims description 21
- 238000000855 fermentation Methods 0.000 title description 20
- 230000004151 fermentation Effects 0.000 title description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 115
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract description 70
- 244000005700 microbiome Species 0.000 claims abstract description 49
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 26
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 18
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 17
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 87
- 239000007789 gas Substances 0.000 claims description 27
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 20
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 14
- 229930195729 fatty acid Natural products 0.000 claims description 14
- 239000000194 fatty acid Substances 0.000 claims description 14
- 150000002430 hydrocarbons Chemical group 0.000 claims description 14
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 11
- 150000004665 fatty acids Chemical class 0.000 claims description 11
- 241000193403 Clostridium Species 0.000 claims description 10
- 239000001569 carbon dioxide Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 9
- 230000000789 acetogenic effect Effects 0.000 claims description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 8
- 241000178985 Moorella Species 0.000 claims description 7
- 102000005488 Thioesterase Human genes 0.000 claims description 7
- 108020002982 thioesterase Proteins 0.000 claims description 7
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 claims description 6
- 241001656809 Clostridium autoethanogenum Species 0.000 claims description 5
- 241001611022 Clostridium carboxidivorans Species 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 150000003973 alkyl amines Chemical class 0.000 claims description 4
- 150000001735 carboxylic acids Chemical class 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 241001468163 Acetobacterium woodii Species 0.000 claims description 3
- 241001656810 Clostridium aceticum Species 0.000 claims description 3
- 150000001299 aldehydes Chemical class 0.000 claims description 3
- 150000001733 carboxylic acid esters Chemical class 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 150000001991 dicarboxylic acids Chemical class 0.000 claims description 3
- 238000011065 in-situ storage Methods 0.000 claims description 3
- 241001112780 Acetoanaerobium Species 0.000 claims description 2
- 241001464894 Blautia producta Species 0.000 claims description 2
- 241000620141 Carboxydothermus Species 0.000 claims description 2
- 241000193161 Clostridium formicaceticum Species 0.000 claims description 2
- 241000186541 Desulfotomaculum Species 0.000 claims description 2
- 241000186398 Eubacterium limosum Species 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 241000205284 Methanosarcina acetivorans Species 0.000 claims description 2
- 241000205275 Methanosarcina barkeri Species 0.000 claims description 2
- 241000193459 Moorella thermoacetica Species 0.000 claims description 2
- 241000191992 Peptostreptococcus Species 0.000 claims description 2
- 241000186429 Propionibacterium Species 0.000 claims description 2
- 241000205160 Pyrococcus Species 0.000 claims description 2
- 241000606008 Ruminobacter amylophilus Species 0.000 claims description 2
- 241000186339 Thermoanaerobacter Species 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- DIAIBWNEUYXDNL-UHFFFAOYSA-N n,n-dihexylhexan-1-amine Chemical group CCCCCCN(CCCCCC)CCCCCC DIAIBWNEUYXDNL-UHFFFAOYSA-N 0.000 claims description 2
- 238000004062 sedimentation Methods 0.000 claims description 2
- ABVVEAHYODGCLZ-UHFFFAOYSA-N tridecan-1-amine Chemical compound CCCCCCCCCCCCCN ABVVEAHYODGCLZ-UHFFFAOYSA-N 0.000 claims description 2
- SWZDQOUHBYYPJD-UHFFFAOYSA-N tridodecylamine Chemical compound CCCCCCCCCCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC SWZDQOUHBYYPJD-UHFFFAOYSA-N 0.000 claims description 2
- 241000193171 Clostridium butyricum Species 0.000 claims 1
- 241000186544 Moorella thermoautotrophica Species 0.000 claims 1
- 241000178986 Oxobacter Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 19
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 45
- 235000019441 ethanol Nutrition 0.000 description 36
- 239000000243 solution Substances 0.000 description 21
- 239000002609 medium Substances 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 15
- 241000588724 Escherichia coli Species 0.000 description 11
- 229910002091 carbon monoxide Inorganic materials 0.000 description 11
- 241000235015 Yarrowia lipolytica Species 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 241000186566 Clostridium ljungdahlii Species 0.000 description 9
- 235000013619 trace mineral Nutrition 0.000 description 9
- 239000011573 trace mineral Substances 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 7
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 235000010633 broth Nutrition 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002309 gasification Methods 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- DBXBTMSZEOQQDU-UHFFFAOYSA-N 3-hydroxyisobutyric acid Chemical compound OCC(C)C(O)=O DBXBTMSZEOQQDU-UHFFFAOYSA-N 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 5
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- JGHZJRVDZXSNKQ-UHFFFAOYSA-N methyl octanoate Chemical compound CCCCCCCC(=O)OC JGHZJRVDZXSNKQ-UHFFFAOYSA-N 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 241000186570 Clostridium kluyveri Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 239000007640 basal medium Substances 0.000 description 3
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 239000003245 coal Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 125000005270 trialkylamine group Chemical group 0.000 description 3
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical class CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 2
- 102100020959 Alpha/beta hydrolase domain-containing protein 17C Human genes 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 240000006262 Cuphea hookeriana Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 241000206672 Gelidium Species 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010364 biochemical engineering Methods 0.000 description 2
- 229920005549 butyl rubber Polymers 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 229960001305 cysteine hydrochloride Drugs 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- -1 fatty acid esters Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- NMRPBPVERJPACX-UHFFFAOYSA-N (3S)-octan-3-ol Natural products CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- WOFPPJOZXUTRAU-UHFFFAOYSA-N 2-Ethyl-1-hexanol Natural products CCCCC(O)CCC WOFPPJOZXUTRAU-UHFFFAOYSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- HWMKUXXLKIOVQZ-UHFFFAOYSA-N 3,6-dimethylpyridin-2-amine Chemical compound CC1=CC=C(C)C(N)=N1 HWMKUXXLKIOVQZ-UHFFFAOYSA-N 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 101710120269 Acyl-CoA thioester hydrolase YbgC Proteins 0.000 description 1
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 1
- 102100025848 Acyl-coenzyme A thioesterase 8 Human genes 0.000 description 1
- 241001534860 Alkalibaculum bacchi Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 241001256038 Clostridium ljungdahlii DSM 13528 Species 0.000 description 1
- 241001611023 Clostridium ragsdalei Species 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 102100030787 ERI1 exoribonuclease 2 Human genes 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241001379910 Ephemera danica Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 101000938751 Homo sapiens ERI1 exoribonuclease 2 Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- XOGTZOOQQBDUSI-UHFFFAOYSA-M Mesna Chemical compound [Na+].[O-]S(=O)(=O)CCS XOGTZOOQQBDUSI-UHFFFAOYSA-M 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 240000003433 Miscanthus floridulus Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- 241001509483 Oxobacter pfennigii Species 0.000 description 1
- 244000302697 Phragmites karka Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- KVODAWHOHSUAKO-UHFFFAOYSA-L [C+2]=O.C(C)(=O)[O-].C(C)(=O)[O-] Chemical compound [C+2]=O.C(C)(=O)[O-].C(C)(=O)[O-] KVODAWHOHSUAKO-UHFFFAOYSA-L 0.000 description 1
- 241000029538 [Mannheimia] succiniciproducens Species 0.000 description 1
- ZLXPLDLEBORRPT-UHFFFAOYSA-M [NH4+].[Fe+].[O-]S([O-])(=O)=O Chemical compound [NH4+].[Fe+].[O-]S([O-])(=O)=O ZLXPLDLEBORRPT-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 108700021044 acyl-ACP thioesterase Proteins 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- HJMZMZRCABDKKV-UHFFFAOYSA-N carbonocyanidic acid Chemical compound OC(=O)C#N HJMZMZRCABDKKV-UHFFFAOYSA-N 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 229940060799 clarus Drugs 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000003546 flue gas Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 229960004635 mesna Drugs 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009331 reductive pathway Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000000629 steam reforming Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
- C12P7/065—Ethanol, i.e. non-beverage with microorganisms other than yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
- C12P7/46—Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/54—Acetic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- the invention relates to processes for the preparation of hydrocarbons substituted by at least one group containing at least one oxygen atom, comprising the process steps
- C0 2 as a carbon source for the synthesis of organic compounds in microbiological processes is often described in the literature.
- the object of the invention was to provide a method which is able to overcome at least one disadvantage of the prior art.
- the present invention therefore provides a method as described in claim 1 and the other independent claims.
- An advantage of the present invention is that C0 2 / CO mixtures are a much cheaper raw material, which can also be produced from various sources, such as natural gas and biogas, coal, oil and plant residues.
- Another advantage of the method according to the invention is the high carbon yield.
- the C0 2 can namely be converted back into acetic acid in the first stage.
- Fermentation conditions, as for the actual production in the process step C) according to the invention another organism is used, as in the carbon fixation in the acetate.
- Yet another advantage of the present invention is that by the use of acetate and / or ethanol, in particular acetate, as the C source in process step C) are different Product compositions may result as if a sugar is used in process step C).
- An object of the present invention is a process for the preparation of at least one group containing at least one oxygen atom
- Hydrocarbons comprising the process steps
- At least one hydrocarbon-substituted group containing at least one oxygen atom and optionally with a second microorganism
- acetate in the context of the present invention is to be understood as meaning both acetic acid and its salts, which necessarily results from the fact that the
- Microorganisms work in an aqueous environment, and thus always there is a balance between salt and acid.
- second microorganism in connection with the present invention is to be understood as other than the "first microorganism” from process step A). All percentages (%) are by mass unless otherwise specified.
- the source of the substrates carbon dioxide and / or carbon monoxide
- any gas or mixture of gases capable of containing the microorganisms can be used to supply sufficient amounts of carbon so that they can form acetate and / or ethanol.
- the carbon source be provided by exhaust gases such as synthesis gas, flue gas, petroleum refinery emissions, yeast fermentation or clostridial fermentation gases, gasification gases from cellulosic materials, or coal gasification.
- exhaust gases such as synthesis gas, flue gas, petroleum refinery emissions, yeast fermentation or clostridial fermentation gases, gasification gases from cellulosic materials, or coal gasification.
- At least part of the carbon dioxide and / or carbon monoxide is a by-product of process step C) of the process according to the invention. This has the technical effect that the
- Synthesis gas can e.g. be provided from the by-product of coal gasification.
- the microorganism thus converts a substance, which is a waste product, into a valuable raw material.
- synthesis gas may be provided by the gasification of widely available, inexpensive agricultural raw materials for the process of the present invention.
- Raw materials are selected from the group comprising perennial grasses such as miscanthus,
- Grain residues processing waste such as sawdust.
- synthesis gas is obtained in a gasification apparatus from dried biomass, mainly by pyrolysis, partial oxidation and steam reforming, wherein the
- the carbon source in process step A) contains at least 50% by weight, preferably at least 70% by weight, particularly preferably at least 90% by weight of CO 2 and / or CO, where the wt % to all carbon sources available to the microorganism in step A).
- process step A preference is given to adding a reducing agent, preferably hydrogen, together with the carbon dioxide and / or carbon monoxide to the reaction.
- a reducing agent preferably hydrogen
- a method preferred according to the invention is characterized in that the carbon source in method step A) comprises synthesis gas, in particular consists of synthesis gas.
- Microorganisms which convert C0 2 and / or CO to acetate and / or ethanol, in particular acetate, and suitable processes and process conditions which are used in process step A) have been known for a long time. Such processes are described, for example, in WO9800558, WO2000014052, WO2010115054
- thermoaceticum Effect of metals on growth yield, enzymes, and the synthesis of acetate from carbon dioxide. Journal of Bacteriology (1973), 1 14 (2), 743-51.
- acetogenic bacteria particularly suitable in this context are acetogenic bacteria.
- the group of acetogenic bacteria belongs to the anaerobic prokaryotes, the C0 2 as terminal
- an acetogenic bacterium is used as the first microorganism.
- acetogenic bacteria selected from the group comprising Clostridium autothenogenum DSMZ 19630, Clostridium ragsdahlei ATCC no. BAA-622, Clostridium autoethanogenum, Moorella sp HUC22-1, Moorella thermoaceticum, Moorella
- thermoautotrophica Rumicoccus productus, Acetoanaerobum, Oxobacter pfennigii,
- Methanosarcina barkeri Methanosarcina acetivorans, Carboxydothermus, Desulfotomaculum kutznetsovii, Pyrococcus, Peptostreptococcus, Butyribacterium methylotrophicum ATCC 33266, Clostridium formicoaceticum, butyricum Clostridium, Lactobacillus delbrukii, Propionibacterium acidoprprionici, Proprionispera arboris, Anaerobierspirillum succiniproducens, Bacteroides amylophilus, Becterioides ruminicola, kivui Thermoanaerobacter, Acetobacterium woodii, Acetoanaerobium notera, Clostridium aceticum, Butyribacterium methylotrophicum, Moorella thermoacetica, Eubacterium limosum, Peptostreptococcus productus, Clostridium ljungdahli
- Clostridium ljungdahlii is Clostridium ljungdahlii, in particular strains selected from the group comprising Clostridium ljungdahlii PETC, Clostridium ljungdahlii ERI2, Clostridium ljungdahlii C0I and Clostridium ljungdahlii 0-52, these are described in WO 98/00558 and WO 00/68407, and ATCC 49587, ATCC 55988 and ATCC 55989.
- ethanol is formed in process step A) and, as microorganism, alkali baculum bacchi ATCC BAA-1772, Moorella sp. HUC22-1, Clostridium ljungdahlii, Clostridium ragsdahlei, or Clostridium autoethanogenum.
- Corresponding instructions for carrying out process step A) are obtained, for example, from Saxena et al. Clostridium ragsdalei. By the ethanologenic acetogen. Journal of Industrial Microbiology & Biotechnology Volume 38, Number 4 (201 1), 513-521, Younesi et al. Ethanol and acetate production from synthesis gas via fermentation processes using anaerobic bacterium clostridium ljungdahlii. Biochemical Engineering Journal Volume 27, Issue 2, 15 December 2005, Pages 110-119,
- Process step A) is preferably carried out under anaerobic conditions.
- process step B) of the process according to the invention the acetate formed in process step A) and / or ethanol, in particular acetate, is separated from the first microorganism.
- the microorganisms are removed, for example, by known methods such as sedimentation, centrifugation or filtration as a solid from the medium containing the acetate and / or ethanol, in particular acetate, and optionally the remaining liquid phase is fed directly to process step C).
- the direct feeding has the advantage that optionally from process step A) additionally contained
- the acetate itself can be removed from the microorganisms in process step A) by means of extraction, in particular by means of in situ extraction.
- Extraction methods are known to those skilled in the art, for example from EP2294206, WO2000014052, US 4405717, from Katikaneni et al. Purification of Fermentation-Derived Acetic Acid By Liquid-Liquid Extraction and Esterification. Ind. Eng. Chem. Res. 2002, 41, 2745-2752, and from Huh et al. Selective extraction of acetic acid from the fermentation broth produced by Mannheimia succiniciproducens. Biotechnol Lett. 2004 Oct; 26 (20): 1581 -4.
- Suitable extractants are described, for example, under point A.
- alkylamines or low-boiling solvents such as MTBE or ethyl acetate are preferably contained as extractants, the alkylamines preferably being those having at least 16 C atoms, preferably trialkylamines and more preferably trialkylamines selected from the group comprising trihexylamine, trioctylamine, tridecylamine, tricaprylamine, tridodecylamine.
- These trialkylamines comprising extractants are preferably used in conjunction with an in situ extraction in step B). This has the technical effect that the first microorganism is not damaged and the additional advantage that process step B) can be carried out in a countercurrent process, which is additionally preferred.
- the extractant used in process step B) is a mixture of trioctylamine and 2-ethyl-1-hexanol, these being preferably used in equal amounts.
- process step C the acetate and / or ethanol, in particular acetate, is reacted with a second microorganism to form a hydrocarbon substituted with at least one group containing at least one oxygen atom.
- Substituted hydrocarbon is preferably carboxylic acids, dicarboxylic acids, hydroxycarboxylic acids, carboxylic acid esters, hydroxycarboxylic acid esters, alcohols, aldehydes, Ketones, which in particular 4 to 32, preferably 6 to 20, particularly preferably 8 to 12 carbon atoms. Particular preference is given to carboxylic acids, hydroxycarboxylic acids and carboxylic esters.
- the second microorganism is preferably yeast or bacteria
- the second microorganism is preferably a genetically modified strain which has been genetically optimized in particular with respect to the yield of the hydrocarbon substituted with at least one group containing at least one oxygen atom.
- WO2011 127409, WO200911 1672 and WO2010062480 suitable second microorganisms and process for the preparation of fatty alcohols
- WO2010126891 for the production of alcohols, fatty acids and fatty acid esters, WO20101 18410, WO201002171 1 and WO2010022090 for the preparation of
- the hydrocarbon substituted by at least one group containing at least one oxygen atom is fatty acids, in particular linear, saturated, fatty acids having 4 to 32, preferably 6 to 20, particularly preferably 8 to 12 carbon atoms.
- the second microorganism is a microorganism which has an increased activity of at least one thioesterase compared to its wild type.
- thioesterases in this connection are selected from acyl-ACP thioesterases, preferably EC 3.1.2.14 or EC 3.1.2.22 and acyl-CoA thioesterases, preferably EC 3.1.2.2, EC 3.1.2.18, EC 3.1.2.19, EC 3.1.2.20 or EC 3.1.2.22.
- Preferred second microorganisms which are used in the alternative according to the invention are disclosed in WO20101 18410, WO2010075483, WO2008119082 and WO2007136762, the disclosure of which is expressly referred to with regard to these microorganisms and with respect to these thioesterases.
- the fatty acid is octane and / or decanoic acid and thioesterase is the gene product of fatB2 from Cuphea hookeriana.
- the hydrocarbon which is substituted by at least one group containing at least one oxygen atom is hydroxycarboxylic acids, in particular omega-hydroxycarboxylic acids or hydroxyisobutyric acids, in particular 3-hydroxyisobutyric acid.
- Microorganism in particular to microorganisms, which in WO2009156214,
- the disclosure content of these documents is expressly referred to with respect to this.
- the second microorganism is in particular microorganisms which are disclosed in WO2011008232, the disclosure content of this document is expressly referred to with respect to this. It is inventively preferred that carbon dioxide formed in process step C) is fed back to the process in process step A) and thus is available as C source. This has the technical effect that the carbon yield is 100%.
- Embodiments should be limited.
- Figure 1 Fatty Acid Production in E. coli of Synthesis Gas Microbially Produced Acetate
- Example 1 Process step A) Acetate and ethanol formation
- a live culture of Clostridium carboxidivorans DSMZ 15243 was prepared in 1 l
- Vitamin solution filled in 1 l of water.
- the pH was adjusted to a pH of 5.9 with 0.5 M NaOH.
- the mineral salt solution consists of 80 g of sodium chloride, 100 g of ammonium chloride, 10 g of potassium chloride, 10 g of potassium monophosphate, 20 g of magnesium sulfate, 4 g of calcium chloride per liter.
- the vitamin solution consists of 0.01 g of pyridoxine, 0.005 g of thiamine, 0.005 g of riboflavin, 0.005 g of calcium pantothenate, 0.005 g of thioctic acid, 0.005 g of (para) -aminobenzoic acid, 0.005 g of nicotinic acid, 0.005 g of vitamin B12, 0.002 g of biotin, 0.002 g of folic acid , 0.01 g MESNA per liter.
- the trace element solution consists of 2 g of nitriloacetic acid, 1 g of manganese sulfate, 0.8 g of iron ammonium sulfate, 0.2 g of cobalt chloride, 0.2 g of zinc sulfate, 0.02 g of copper (II) chloride, 0.02 g of nickel chloride, 0 , 02 g of sodium molybdate, 0.02 g of sodium selenate, 0.02 g of sodium tungstate per liter.
- the medium was boiled for 20 minutes and then fumigated with pure nitrogen for 20 minutes. Thereafter, it was autoclaved for 20 minutes at 121 ° C. After cooling, the medium was fed 3 times with a gas mixture of 50% CO, 45% H 2 and 5% CO 2 up to 1 bar overpressure. Thereafter, the pressure was set to 0.8 bar overpressure. Immediately before inoculation was carried out under sterile, anaerobic conditions, the addition of 1, 5 ml of a 4% solution of sodium sulfite / cysteine hydrochloride as a reducing agent.
- the culture was cultured at 37 ° C with 100 rpm (5 cm eccentricity). The culture was inoculated after 72 hours in a new medium.
- the pH was adjusted to 5.9 with 0.5 M NaOH and 0.5 M HCl throughout the fermentation.
- the gas mixture was adjusted to 80% CO and 20% CO 2 using a gas mixing station WMR 4000 from Westphal Mess- und Regeltechnik. Fumigation was constant at 5 l / h.
- the stirrer speed was set to a constant 400 rpm, which corresponds to a power input of 0.2 W / l.
- the inoculum was 10% and was also added under sterile, anaerobic conditions 30 minutes after the start of fumigation.
- the starting OD 6 oo was 0.055.
- High performance liquid chromatography determined.
- the column Aminex HPX-87H was used as a stationary phase.
- the eluent used was 5 mM sulfuric acid at a constant flow rate of 0.6 ml / min.
- the temperature of the column was 40 ° C.
- the detection of ethanol and butanol was carried out by means of a refractive index detector, for the detection of acetic acid and butyric acid, a diode array detector at a wavelength of 210 nm was used.
- the substance concentrations were determined by the peak area on the basis of
- the pH of the fermentation broth was lowered to a pH of less than 3.0 after separation of the cells by the addition of acetic acid. Thereafter, a tri-n-octylamine solution in 1-octanol in the ratio 1: 1 was added to the fermentation broth and mixed at a stirrer speed of at least 1000 rpm at 25 ° C for up to 2 hours with the fermentation broth. The subsequent phase separation was carried out by centrifugation. From the organic phase was then at 120 ° C and 500 mbar overpressure the acetic acid is distilled. The acetic acid content of the distillate was determined by HPLC and the solution was used in the corresponding concentration in the further fermentation (compare Example 3 and 4 and 6).
- Example 3 Reaction of acetate to C8 and C10 fatty acids in recombinant E. coli
- Yeast extract 10 g peptone, 0.5 g sodium chloride and 15 g agar-agar pH 7 streaked.
- the strain E. coli JW5020-1 (AfadE) pJ294 [Ptac-ChFATB2_optEc] was streaked with an inoculation loop from a cryoculture on an LB plate containing additionally 100 mg / ml ampicillin. The plates were incubated overnight at 37 ° C.
- the strain E. coli JW5020-1 (AfadE) pJ294 [Ptac-ChFATB2_optEc] is transformed with an expression vector for the gene fatB2 from Cuphea hookeriana.
- this gene was codon-optimized for expression in Escherichia coli.
- the gene was synthesized together with a fac promoter and simultaneously a
- the synthesized DNA fragment P tac -ChFatB2 (SEQ ID NO. 1). was digested with the restriction endonucleases BamH ⁇ and Noü and ligated into the appropriately cut vector pJ294 (DNA2.0 Inc., Menlo Park, CA, USA).
- the completed E. coli expression vector was designated pJ294 [Ptac-ChFATB2_optEc] (SEQ ID NO: 2).
- Preculture 1 Both cultures were inoculated into 10 ml of M9, mod-G liquid medium in 100 ml shake flasks with baffles.
- the M9 mod-G medium is composed of 2.6 g / l (NH 4 ) 2 S0 4 , 0.49 g / l MgS0 + 7H 2 0, 20 g / l glucose, 1 ml / l of trace elements US3 dissolved in 800 ml M9 buffer and 150 ml ddH 2 0.
- the M9 buffer consists of 6.79 g / l Na 2 HPO 2 + 2H 2 0, 3 g / l KH 2 P0, 0.5 g / l NaCl, 2 g / l NH CI dissolved in 800 ml ddH 2 0.
- 100 ⁇ g / ml ampicillin were added to the medium.
- the cultures were incubated at 37 ° C and 200rpm overnight.
- M9, mod-G medium is composed of 2.6 g / l (NH 4 ) 2 S0 4 , 0.49 g / l MgS0 + 7H 2 O, 60 mM sodium acetate (from Example 2), 1 ml / l Trace elements US3 dissolved in 800 ml M9 buffer and 170 ml ddH 2 0.
- 100 ug / ml ampicillin was added for the culture of the plasmid-carrying strain.
- the cultures were incubated at 37 ° C and 200 rpm overnight.
- IPTG was induced with 1 mM IPTG from a stock solution of 1 M.
- the quantification of fatty acids was carried out after derivatization as fatty acid methyl ester by gas chromatography.
- samples consisting of 2 ml of culture broth, 50 ⁇ l of heptadecanoic acid (10 g / l dissolved in ethanol) were added as internal reference substance after addition of 1 ml of acetone and 2 ml of water.
- the samples were acidified with 200 ⁇ acetic acid and added with 10 ml of a 1: 1 (v / v) chloroform / methanol mixture.
- the samples were vigorously mixed for at least 1 min. Subsequently, the chloroform phase was removed and evaporated.
- the dry residue was taken up in 1 ml of 1, 25 M methanolic hydrochloric acid and incubated at 50 ° C overnight to esterify the fatty acids.
- the reaction was stopped by adding 5 ml of saturated Natnumcarbonatants (all substances Sigma-Aldrich, Steinheim).
- the extraction of the fatty acid methyl esters was carried out by adding 1 ml of n-heptane and vigorous mixing for 15 seconds.
- the heptane phase is measured by gas chromatography.
- the capillary column SP TM -2560 with the dimensions 100 mx 0.25 mm and a film thickness of 0.2 ⁇ m (Supelco, Sigma-Aldrich, Steinheim) was used as the stationary phase.
- Helium was used as the carrier gas. The separation took place within 45 min with an injector temperature of 260 ° C, detector temperature of 260 ° C and column temperature of 140 ° C at the beginning, held for 5 min and raised to 240 ° C at a rate of 4 ° C / min and held for 15 min. The injection volume is 1 ⁇ , the split rate 1:20 and the flow rate of the carrier gas 1 ml / min. The detection was carried out by means of flame ionization detector (GC Perkin Elmer Clarus 500, Perkin Elmer, Rodgau). Heptadecanoic acid (Sigma-Aldrich, Steinheim) was used as internal
- Palmitic acid methyl ester C16: 1 -Me palmitoleic acid methyl ester, C18: 0-Me
- Methyl stearate, C18: 1 Me methyl ester (GLC Standard Mix GLC-20 1892-1AMP, GLC-30 1893-1AMP, GLC-50 1894-1AMP, Sigma-Aldrich, Steinheim) were used for calibration. The limits of determination are for all fatty acid methyl esters at a concentration of 10 mg / l.
- ChFATB2_optEc] after 96 hours normalizes to an OD of 1 as shown in Figure 1.
- Example 4 Reaction of acetate to 3-hydroxyisobutyric acid (3-HIB) with Yarrowia lipolytica H222-41 A3HIBDH (ura) -8
- Example 1 a Y. lipolytica cell H222-41 having a weakened activity of 3-hydroxyiosbutyric acid dehydrogenase was prepared; this cell is called H222-41 ⁇ 3HIBDH (ura) -8 below.
- H222-41 ⁇ 3HIBDH (ura) -8 was cultured in comparison with the corresponding wild-type H222-41 (ura) -8. cultivation
- YEPD agar plates consist of 10 g glucose, 10 g yeast extract, 20 g peptone and 15 g agar agar. The pH is 5.4. The incubation was carried out at 25 ° C for 80 hours. Preculture (biomass production)
- Acetate medium made up to 50 ml each.
- the van Uden acetate medium is composed as follows:
- the OD increases in the test period from an average of 10 to an average of 45.
- the acetate content at the beginning was on average 2250 mg / kg, at the end of the fermentation 32 mg / l.
- the 3HIB content at the beginning of the fermentation is in both Y. lipolytica H222-41 ⁇ 3HIBDH (ura) -8 and Y. lipolytica H222-41 (ura) -8 0 mg / l.
- Dehydrogenase has produced an average of 18 mg / kg 3HIB.
- Example 5 Process step B) Ethanol separation The separation of ethanol in the form of an aqueous concentrate was carried out by direct distillation of the fermentation broth from Example 1.
- Example 6 Reaction of acetate and ethanol to form hexanoic acid and ethylhexylate with the anaerobic bacterium Clostridium kluyveri
- pressure-resistant glass bottles which can be hermetically sealed with a butyl rubber stopper, were used. All cultivation steps were carried out under anaerobic conditions. The bottles were autoclaved at 121 ° C for 20 minutes to ensure sterility.
- Hexanoic acid / hexanoic acid ethyl ester here the total value rose from 0.05 g / L to 7.6 g / L, be shown.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE201210207921 DE102012207921A1 (de) | 2012-05-11 | 2012-05-11 | Mehrstufiges Syntheseverfahren mit Synthesegas |
PCT/EP2013/059608 WO2013167663A2 (de) | 2012-05-11 | 2013-05-08 | Mehrstufiges syntheseverfahren mit synthesegas |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2847340A2 true EP2847340A2 (de) | 2015-03-18 |
Family
ID=48607211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13728123.4A Pending EP2847340A2 (de) | 2012-05-11 | 2013-05-08 | Mehrstufiges fermentationsverfahren ausgehend von synthesegas |
Country Status (10)
Country | Link |
---|---|
US (1) | US10787688B2 (es) |
EP (1) | EP2847340A2 (es) |
KR (1) | KR102180340B1 (es) |
CN (2) | CN104271751A (es) |
BR (1) | BR112014029571B1 (es) |
CA (1) | CA2872914C (es) |
DE (1) | DE102012207921A1 (es) |
MX (1) | MX2014013670A (es) |
WO (1) | WO2013167663A2 (es) |
ZA (1) | ZA201409014B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2602328A1 (de) * | 2011-12-05 | 2013-06-12 | Evonik Industries AG | Verfahren zur Oxidation von Alkanen unter Verwendung einer AlkB Alkan 1-Monooxygenase |
EP2631298A1 (en) | 2012-02-22 | 2013-08-28 | Evonik Industries AG | Biotechnological method for producing butanol and butyric acid |
DE102012207921A1 (de) | 2012-05-11 | 2013-11-14 | Evonik Industries Ag | Mehrstufiges Syntheseverfahren mit Synthesegas |
EP2759598A1 (de) | 2013-01-24 | 2014-07-30 | Evonik Industries AG | Verfahren zur Herstellung von alpha, omega-Alkandiol |
EP2944697A1 (en) * | 2014-05-13 | 2015-11-18 | Evonik Degussa GmbH | Method of producing nylon |
EP2944696A1 (en) | 2014-05-13 | 2015-11-18 | Evonik Degussa GmbH | Method of producing organic compounds |
EP3050967A1 (en) * | 2015-01-28 | 2016-08-03 | Evonik Degussa GmbH | A method of producing higher alcohols |
EP3050966A1 (en) | 2015-01-28 | 2016-08-03 | Evonik Degussa GmbH | An aerobic method of producing alcohols |
CN105087441B (zh) * | 2015-08-20 | 2018-11-30 | 安徽省中科通源环境科技有限公司 | 一种复合菌群及其在合成气发酵产醇中的应用 |
WO2017102952A1 (en) | 2015-12-17 | 2017-06-22 | Evonik Degussa Gmbh | A genetically modified acetogenic cell |
EP3490969B1 (en) | 2016-07-27 | 2020-07-22 | Evonik Operations GmbH | N-acetyl homoserine |
US11649472B2 (en) * | 2017-06-30 | 2023-05-16 | Massachusetts Institute Of Technology | Controlling metabolism by substrate cofeeding |
AU2019220419B2 (en) * | 2018-02-15 | 2023-12-07 | Evonik Operations Gmbh | Extraction of alkanoic acids |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4720457A (en) * | 1984-12-20 | 1988-01-19 | Canadian Patents And Development Ltd. | Selective production of ethyl acetate and acetaldehyde by microorganisms |
WO2009058028A1 (en) * | 2007-10-28 | 2009-05-07 | Lanzatech New Zealand Limited | Improved carbon capture in fermentation |
WO2010042664A2 (en) * | 2008-10-07 | 2010-04-15 | Ls9, Inc. | Method and compositions for producing fatty aldehydes |
WO2011127409A2 (en) * | 2010-04-08 | 2011-10-13 | Ls9, Inc. | Methods and compositions related to fatty alcohol biosynthetic enzymes |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405717A (en) | 1981-10-26 | 1983-09-20 | Cpc International Inc. | Recovery of acetic acid from a fermentation broth |
US5807722A (en) | 1992-10-30 | 1998-09-15 | Bioengineering Resources, Inc. | Biological production of acetic acid from waste gases with Clostridium ljungdahlii |
UA72220C2 (uk) | 1998-09-08 | 2005-02-15 | Байоенджініерінг Рісорсиз, Інк. | Незмішувана з водою суміш розчинник/співрозчинник для екстрагування оцтової кислоти, спосіб одержання оцтової кислоти (варіанти), спосіб анаеробного мікробного бродіння для одержання оцтової кислоти (варіанти), модифікований розчинник та спосіб його одержання |
ES2216506T3 (es) | 1999-05-07 | 2004-10-16 | Emmaus Foundation, Inc. | Cepas de clostridum que producen etanol a partir de gases que contienen substratos. |
US6519771B1 (en) | 1999-12-14 | 2003-02-11 | Steven Ericsson Zenith | System for interactive chat without a keyboard |
EP1350788A3 (de) | 2002-03-28 | 2003-11-12 | Degussa AG | Verfahren zur Herstellung von Hexamethylendiamin aus Butadien |
US7129067B2 (en) | 2002-06-28 | 2006-10-31 | Takasago International Corporation | Method for producing lactone |
CA2633020C (en) | 2005-12-30 | 2014-04-15 | Council Of Scientific & Industrial Research | Process for preparing long-chain dicarboxylic acids |
CA2647150A1 (en) | 2006-03-15 | 2007-09-20 | Martek Biosciences Corporation | Plant seed oils containing polyunsaturated fatty acids |
DE102006017760A1 (de) | 2006-03-24 | 2007-09-27 | Ufz-Umweltforschungszentrum Leipzig-Halle Gmbh | Verfahren zur enzymatischen Herstellung von 2-Hydroxy-2-methylcarbonsäuren |
US20100274033A1 (en) | 2009-04-27 | 2010-10-28 | Ls9, Inc. | Production of fatty acid esters |
US8110670B2 (en) * | 2006-05-19 | 2012-02-07 | Ls9, Inc. | Enhanced production of fatty acid derivatives |
WO2007136762A2 (en) | 2006-05-19 | 2007-11-29 | Ls9, Inc. | Production of fatty acids and derivatives thereof |
US20070275447A1 (en) | 2006-05-25 | 2007-11-29 | Lewis Randy S | Indirect or direct fermentation of biomass to fuel alcohol |
DE102006025821A1 (de) | 2006-06-02 | 2007-12-06 | Degussa Gmbh | Ein Enzym zur Herstellung von Mehylmalonatsemialdehyd oder Malonatsemialdehyd |
US7704723B2 (en) | 2006-08-31 | 2010-04-27 | The Board Of Regents For Oklahoma State University | Isolation and characterization of novel clostridial species |
NZ553984A (en) * | 2007-03-19 | 2009-07-31 | Lanzatech New Zealand Ltd | Alcohol production process |
BRPI0809345A2 (pt) | 2007-03-28 | 2014-10-07 | Ls9 Inc | Células recombinantes, composições produzidas por estas, métodos para produzir derivados de ácidos graxos em uma célula recombinante, para aumentar a produção de derivados de ácidos graxos em uma célula recombinante, construto recombinante, vetores, métodos para aumentar a produção de derivados de ácidos graxos em uma célula hospedeira de produção, para produzir derivados de ácidos graxos, derivados de ácidos graxos, composições de biocombustível. |
DE102007027006A1 (de) | 2007-06-08 | 2008-12-11 | Evonik Degussa Gmbh | Mikrobiologische Herstellung von Aldehyden, insbesondere von 3-Hydroxypropionaldehyd |
DE102007041862A1 (de) | 2007-09-03 | 2009-03-19 | Evonik Degussa Gmbh | Mikrobiologische Herstellung von Isoprenoiden |
SG186647A1 (en) | 2007-12-13 | 2013-01-30 | Glycos Biotechnologies Inc | Microbial conversion of oils and fatty acids to high-value chemicals |
DE102007060705A1 (de) | 2007-12-17 | 2009-06-18 | Evonik Degussa Gmbh | ω-Aminocarbonsäuren oder ihre Lactame, herstellende, rekombinante Zellen |
CN101990576A (zh) * | 2008-02-07 | 2011-03-23 | 齐凯姆公司 | 丁醇和己醇的间接制造 |
EP2262901B1 (en) | 2008-03-05 | 2018-11-21 | Genomatica, Inc. | Primary alcohol producing organisms |
EP2108702A1 (en) | 2008-04-07 | 2009-10-14 | Organo Balance GmbH | Synthesis of polyunsaturated fatty acids in yeast |
JP2011519561A (ja) | 2008-05-01 | 2011-07-14 | ジェノマティカ, インコーポレイテッド | メタクリル酸の産生のための微生物 |
CN105112454B (zh) | 2008-05-16 | 2017-01-18 | Reg生命科学有限责任公司 | 产生碳氢化合物的方法和组合物 |
DE102008002715A1 (de) | 2008-06-27 | 2009-12-31 | Evonik Röhm Gmbh | 2-Hydroxyisobuttersäure produzierende rekombinante Zelle |
DE102008040193A1 (de) * | 2008-07-04 | 2010-01-07 | Evonik Röhm Gmbh | Verfahren zur Herstellung freier Carbonsäuren |
DE102008040415A1 (de) | 2008-07-15 | 2010-01-21 | Evonik Röhm Gmbh | Thermisches Salzspalten von Ammoniumcarboxylaten |
US20100071259A1 (en) | 2008-08-18 | 2010-03-25 | Ls9, Inc. | Systems and methods for production of mixed fatty esters |
WO2010022763A1 (en) * | 2008-08-25 | 2010-03-04 | Metabolic Explorer | Method for the preparation of 2-hydroxy-isobutyrate |
CN105154380B (zh) | 2008-10-28 | 2018-11-09 | Reg生命科学有限责任公司 | 用于产生脂肪醇的方法和组合物 |
MX2011006785A (es) | 2008-12-23 | 2011-09-27 | Ls9 Inc | Metodos y composiciones relacionados con tioesterasa enzima. |
US8178329B2 (en) | 2009-04-01 | 2012-05-15 | Richard Allen Kohn | Process to produce organic compounds from synthesis gases |
WO2010118410A1 (en) | 2009-04-10 | 2010-10-14 | Ls9, Inc. | Production of fatty acid derivatives |
WO2010127318A2 (en) | 2009-05-01 | 2010-11-04 | The Regents Of The University Of California | Product of fatty acid esters from biomass polymers |
DE102009002811A1 (de) | 2009-05-05 | 2010-11-11 | Evonik Degussa Gmbh | Enzymatisches Verfahren zur Herstellung von Aldehyden |
US8158391B2 (en) | 2009-05-06 | 2012-04-17 | Dna Twopointo, Inc. | Production of an α-carboxyl-ω-hydroxy fatty acid using a genetically modified Candida strain |
GB2487866A (en) | 2009-09-27 | 2012-08-08 | Opx Biotechnologies Inc | Method for producing 3-Hydroxypropionic acid and other products |
WO2011059745A1 (en) | 2009-10-28 | 2011-05-19 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Bacterium for production of fatty acids |
DE102009046626A1 (de) | 2009-11-11 | 2011-05-12 | Evonik Degussa Gmbh | Candida tropicalis Zellen und deren Verwendung |
DE102010015807A1 (de) | 2010-04-20 | 2011-10-20 | Evonik Degussa Gmbh | Biokatalytisches Oxidationsverfahren mit alkL-Genprodukt |
BR112012027464A2 (pt) | 2010-06-04 | 2019-09-24 | Novozymes Inc | célula hospedeira, método para produzir um ácido dicarboxílico c4, e, método para aumentar a produção de ácido dicarboxílico c4. |
WO2011157573A2 (de) | 2010-06-14 | 2011-12-22 | Evonik Röhm Gmbh | Ein enzym zur herstellung von methylmalonatsemialdehyd |
CN103080305B (zh) | 2010-06-18 | 2014-12-24 | 丹麦科技大学 | 酵母由木质纤维素和甘油生产生物柴油 |
DK2601292T3 (en) | 2010-08-06 | 2018-07-16 | Biopetrolia Ab | METHODS AND PRODUCTS FOR MANUFACTURING GROWERS |
EP2606138A2 (en) | 2010-08-19 | 2013-06-26 | Lanzatech New Zealand Limited | A process for producing chemicals using microbial fermentation of substrates comprising carbon monoxide |
BR112013006883A2 (pt) | 2010-09-24 | 2016-06-07 | Dsm Ip Assets Bv | processo de produção de ácido dicarboxílico |
EP2557176A1 (en) | 2011-06-15 | 2013-02-13 | Evonik Degussa GmbH | Enzymatic amination |
ES2604335T3 (es) | 2011-07-20 | 2017-03-06 | Evonik Degussa Gmbh | Oxidación y aminación de alcoholes primarios |
CN107034247A (zh) | 2011-08-05 | 2017-08-11 | 赢创德固赛有限公司 | 仲醇的氧化和胺化 |
DE102011110945A1 (de) * | 2011-08-15 | 2013-02-21 | Evonik Degussa Gmbh | Biotechnologisches Syntheseverfahren von organischen Verbindungen mit alkIL-Genprodukt |
DE102011110946A1 (de) | 2011-08-15 | 2016-01-21 | Evonik Degussa Gmbh | Biotechnologisches Syntheseverfahren von omegafunktionalisierten Carbonsäuren und Carbonsäure-Estern aus einfachen Kohlenstoffquellen |
EP2602328A1 (de) | 2011-12-05 | 2013-06-12 | Evonik Industries AG | Verfahren zur Oxidation von Alkanen unter Verwendung einer AlkB Alkan 1-Monooxygenase |
EP2602329A1 (de) * | 2011-12-05 | 2013-06-12 | Evonik Degussa GmbH | Biotechnologische Herstellung von 3-Hydroxyisobuttersäure |
EP2607479A1 (en) | 2011-12-22 | 2013-06-26 | Evonik Industries AG | Biotechnological production of alcohols and derivatives thereof |
EP2607490A1 (de) | 2011-12-22 | 2013-06-26 | Evonik Industries AG | Verfahren zur verbesserten Abtrennung einer hydrophoben organischen Lösung von einem wässrigen Kulturmedium |
EP2620504A1 (en) | 2012-01-25 | 2013-07-31 | Evonik Industries AG | Process for oxidizing alkenes employing the Pseudomonas putida GPo1 AlkB monooxygenase |
EP2631298A1 (en) | 2012-02-22 | 2013-08-28 | Evonik Industries AG | Biotechnological method for producing butanol and butyric acid |
EP2639308A1 (de) | 2012-03-12 | 2013-09-18 | Evonik Industries AG | Enzymatische omega-Oxidation und -Aminierung von Fettsäuren |
EP2647696A1 (de) | 2012-04-02 | 2013-10-09 | Evonik Degussa GmbH | Verfahren zur aeroben Herstellung von Alanin oder einer unter Verbrauch von Alanin entstehenden Verbindung |
EP2653538A1 (de) | 2012-04-20 | 2013-10-23 | Evonik Industries AG | NADP-abhängige Alanindehydrogenase |
DE102012207921A1 (de) | 2012-05-11 | 2013-11-14 | Evonik Industries Ag | Mehrstufiges Syntheseverfahren mit Synthesegas |
EP2674489A1 (en) | 2012-06-15 | 2013-12-18 | Evonik Industries AG | Biotechnological 2-hydroxyisobutyric acid production |
EP2733215A1 (en) | 2012-11-20 | 2014-05-21 | Evonik Industries AG | Process for producing alpha,omega-diols from alkanes or 1-alkanols employing a CYP153 alkane hydroxylase |
EP2746397A1 (de) | 2012-12-21 | 2014-06-25 | Evonik Industries AG | Herstellung von Omega-Aminofettsäuren |
EP2759598A1 (de) | 2013-01-24 | 2014-07-30 | Evonik Industries AG | Verfahren zur Herstellung von alpha, omega-Alkandiol |
DE102013202106A1 (de) | 2013-02-08 | 2014-08-14 | Evonik Industries Ag | Autotrophe Kultivierung |
-
2012
- 2012-05-11 DE DE201210207921 patent/DE102012207921A1/de not_active Withdrawn
-
2013
- 2013-05-08 KR KR1020147031243A patent/KR102180340B1/ko active IP Right Grant
- 2013-05-08 MX MX2014013670A patent/MX2014013670A/es unknown
- 2013-05-08 WO PCT/EP2013/059608 patent/WO2013167663A2/de active Application Filing
- 2013-05-08 CN CN201380024696.5A patent/CN104271751A/zh active Pending
- 2013-05-08 CA CA2872914A patent/CA2872914C/en active Active
- 2013-05-08 CN CN202010735971.6A patent/CN111850053A/zh active Pending
- 2013-05-08 US US14/400,379 patent/US10787688B2/en active Active
- 2013-05-08 BR BR112014029571-9A patent/BR112014029571B1/pt active IP Right Grant
- 2013-05-08 EP EP13728123.4A patent/EP2847340A2/de active Pending
-
2014
- 2014-12-09 ZA ZA2014/09014A patent/ZA201409014B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4720457A (en) * | 1984-12-20 | 1988-01-19 | Canadian Patents And Development Ltd. | Selective production of ethyl acetate and acetaldehyde by microorganisms |
WO2009058028A1 (en) * | 2007-10-28 | 2009-05-07 | Lanzatech New Zealand Limited | Improved carbon capture in fermentation |
WO2010042664A2 (en) * | 2008-10-07 | 2010-04-15 | Ls9, Inc. | Method and compositions for producing fatty aldehydes |
WO2011127409A2 (en) * | 2010-04-08 | 2011-10-13 | Ls9, Inc. | Methods and compositions related to fatty alcohol biosynthetic enzymes |
Non-Patent Citations (1)
Title |
---|
See also references of WO2013167663A2 * |
Also Published As
Publication number | Publication date |
---|---|
CA2872914A1 (en) | 2013-11-14 |
MX2014013670A (es) | 2015-09-04 |
DE102012207921A1 (de) | 2013-11-14 |
KR20150016231A (ko) | 2015-02-11 |
US10787688B2 (en) | 2020-09-29 |
WO2013167663A2 (de) | 2013-11-14 |
CN104271751A (zh) | 2015-01-07 |
CN111850053A (zh) | 2020-10-30 |
BR112014029571A2 (pt) | 2017-06-27 |
WO2013167663A3 (de) | 2014-01-23 |
BR112014029571B1 (pt) | 2022-02-01 |
CA2872914C (en) | 2022-01-11 |
US20150125912A1 (en) | 2015-05-07 |
ZA201409014B (en) | 2016-03-30 |
KR102180340B1 (ko) | 2020-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2847340A2 (de) | Mehrstufiges fermentationsverfahren ausgehend von synthesegas | |
KR101742835B1 (ko) | 알코올 제조방법 | |
EP2421960B1 (de) | Zellen und verfahren zur herstellung von aceton | |
KR101317447B1 (ko) | 알코올 제조 방법 | |
US8673603B2 (en) | Fermentation process for controlling butanediol production | |
US8119844B2 (en) | Alcohol production process | |
US20110250629A1 (en) | Alcohol production process | |
KR102678516B1 (ko) | 알칸산의 추출 | |
Harry-O’kuru et al. | Bio-generation of succinic acid by fermentation of Physaria fendleri seed polysaccharides | |
CN109486868B (zh) | 一种以木质纤维素为原料发酵生产异丙醇和丁醇的方法 | |
JP2024507194A (ja) | 6-ウンデカノールエステルを含む水性組成物 | |
WO2009098301A1 (de) | Behandlung salz- und glycerin-haltiger rückstände | |
RU2785987C2 (ru) | Экстракция алкановых кислот | |
JP7430244B2 (ja) | 脂肪族アルコールの抽出 | |
RU2807367C2 (ru) | Экстракция алифатических спиртов | |
RU2788086C2 (ru) | Способ получения 6-ундеканона и его производных | |
WO2011145956A1 (en) | Alcohol production process | |
Tran | Fermentation inhibitors and their recovery from acid wood hydrolyzates as chemicals of value | |
JP2010273599A (ja) | グリセリン誘導体の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20141022 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: EVONIK DEGUSSA GMBH |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180716 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: EVONIK OPERATIONS GMBH |